| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8210396 | Applied Radiation and Isotopes | 2014 | 7 Pages | 
Abstract
												The translocator protein (TSPO) ligand 2-(6,8-dichloro-2-(4-ethoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-N-(2-fluoropyridin-3-yl)-N-methylacetamide (PBR170), is a novel imidazopyridineacetamide with high affinity (2.6 nm) and selectivity for the TSPO. The synthesis of [11C]PBR170 was accomplished by N-methylation of the corresponding desmethyl precursor with [11C]methyl iodide in the presence of sodium hydroxide in dimethylformamide. [11C]PBR170 was produced in 30-45% radiochemical yield (decay-corrected, based on [11C]methyl iodide) with a radiochemical purity >98% and a specific activity of 90-190 GBq/μmol after 35 min of synthesis time.
											Keywords
												
											Related Topics
												
													Physical Sciences and Engineering
													Physics and Astronomy
													Radiation
												
											Authors
												Thomas Bourdier, David Henderson, Christopher J.R. Fookes, Peter Lam, Filomena Mattner, Michael Fulham, Andrew Katsifis, 
											![First Page Preview: Synthesis of [11C]PBR170, a novel imidazopyridine, for imaging the translocator protein with PET Synthesis of [11C]PBR170, a novel imidazopyridine, for imaging the translocator protein with PET](/preview/png/8210396.png)